Thromb Haemost 2000; 84(01): 118-123
DOI: 10.1055/s-0037-1613978
Commentary
Schattauer GmbH

Effect of Strenuous Arm Exercise on Oxidized-LDL-Potentiated Platelet Activation in Individuals with Spinal Cord Injury

Jong-Shyan Wang
3   From the Department of Physical Therapy, Chang Gung University, Taoyuan, Taiwan
,
Chih Fang Yang
1   Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital, Taoyuan, Taiwan
,
May-Kuen Wong
1   Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital, Taoyuan, Taiwan
,
Shu-Er Chow
2   Department of Physiology, Chang Gung University, Taoyuan, Taiwan
,
Jan-Kan Chen
2   Department of Physiology, Chang Gung University, Taoyuan, Taiwan
› Institutsangaben
The study was support under the National Science Council Grant NSC 90-2320-B-182-006. The authors would like to thank the volunteers for their enthusiastic participation in this study.
Weitere Informationen

Publikationsverlauf

Received 03. Januar 2000

Accepted after revision 21. Februar 2000

Publikationsdatum:
10. Dezember 2017 (online)

Summary

This study investigates how strenuous arm exercise affects oxidizedlow density lipoprotein (Ox-LDL) mediated-platelet activation in patients with SCI. Ten patients with SCI and ten age- and sex-matched healthy subjects exercised strenuously using an arm crank ergometer. The following measurements were taken both when the subjects were at rest, and immediately after exercise: plasma lipid profile, Ox-LDL mediated platelet aggregability and [Ca2+]i, urinary 11-dehydro-thromboxane B2 (11-dehydro-TXB2) and 8-iso-prostaglandin F. (8-iso-PG F.) contents, and plasma NO metabolite (nitrite plus nitrate) level. Based on these measurements, the major findings of this study can be summarized as follows: 1) the SCI group had higher urinary 8-iso- PGF. and 11-dehydro-TXB2 contents, but a lower plasma nitrite plus nitrate level than the control group; 2) at rest, the SCI group had a higher platelet aggregability and [Ca2+]i, and Ox-LDL-potentiated platelet activation than the control group; 3) Ox-LDL-potentiated platelet aggregation was enhanced by strenuous arm exercise in both groups, but the effect of exercise was more pronounced in the SCI group than in the control group; 4) treating the platelet with L-arginine inhibited Ox-LDL-potentiated platelet activation in both groups. The study concludes that individuals with SCI had more extensive resting and exercise-enhanced Ox-LDL-potentiated platelet activation and greater amounts of preformed lipid peroxides than those without SCI. Therefore, supplementation therapy with antioxidants may be needed for patients with SCI, especially in a strenuous arm exercise period.

 
  • References

  • 1 Yekutiel M, Brooks ME, Ohry A, Yarom J, Carel R. The prevalence of hypertension, ischaemic heart disease and diabetes in traumatic spinal cord injured patients and amputees. Paraplegia 1989; 27: 58-62.
  • 2 Wolf N. Thrombosis and arteriosclerosis. Br Med Bull 1978; 34: 137-42.
  • 3 Fitzgerald DJ, Roy L, Catella F, FitzGerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315: 983-9.
  • 4 Siscovick DS, Weiss NS, Fletcher RH, Lasky T. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med 1984; 311: 874-7.
  • 5 Corrado D, Thiene G, Nava A, Rossi L, Pennelli N. Sudden death in young competitive athletes: clinicopathological correlations in 22 cases. Am J Med 1990; 89: 588-96.
  • 6 Wang JS, Jen CJ, Kung HC, Lin LJ, Hsiue TR, Chen H-I. Effects of strenuous exercise and moderate exercise on platelet function in males. Circulation 1994; 90: 2877-85.
  • 7 Wang JS, Jen CJ, Chen H-I. Effects of exercise training and deconditioning on platelet function in males. Arterioscler Thromb Vasc Biol 1995; 15: 1668-74.
  • 8 Hoffman MD. Cardiorespiratory fitness and training in quadriplegics and paraplegics. Sport Med 1986; 03: 312-30.
  • 9 Glaser RM, Davis GM. Wheelchair-dependent individuals. In: Franklin BA, Gordon S, Timmis GC. eds. Exercise in modern medicine . Baltimore: Williams & Wilkins; 1989: 237-67.
  • 10 Jenkins RR. Free radical chemistry. Relationship to exercise. Sports Med 1988; 05: 156-70.
  • 11 Freeman BA, Crapo JD. Free radicals and tissue damage. Lab Invest 1982; 47: 412-26.
  • 12 Koller E, Vukovich T, Doleschel W, Auerswald W. The influence of liproproteins on ADP-induced platelet aggregation. Atherogenase 1979; 04 (suppl IV): 53-8.
  • 13 Hassall DG, Owen JS, Bruckdorfer KR. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin. Biochem J 1983; 216: 43-9.
  • 14 Sanchez-Quesada JL, Homs-Serradesanferm R, Serrat-Serrat J, Serra-Grima JR, Gonzalez-Sastre F, Ordonez-Llanos J. Increase of LDL susceptibility to oxidation occurring after intense, long duration aerobic exercise. Atherosclerosis 1995; 118: 297-305.
  • 15 Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS 1993; 334: 170-4.
  • 16 Frank L, Massaro D. Oxygen toxicity. Am J Med 1980; 69: 117-26.
  • 17 Liao W, Jin XY, Wang BH, Cui XS, Wang JL, Zhang J, Zhou TJ. Impaired blood superoxide dismutase in traumatic paraplegic patients. Acta Neurol Scand 1992; 86: 329-31.
  • 18 Patrono C, FitzGerald GA. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscl Thromb Vas 1997; 17: 2309-15.
  • 19 Moncada S, Vane J. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med 1979; 300: 1142-7.
  • 20 Tofler GH, Brezinski D, Schafer AI, Czeisler CA, Rutherford TD, Williams GH, Muller JE. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987; 316: 1514-8.
  • 21 Taylor HL, Buskirk E, Heuschel A. Maximal oxygen intake as an objective measurement of cardiorespiratory performance. J Appl Physiol 1955; 08: 73-80.
  • 22 Havel RJ, Eder HA, Bradgon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345-53.
  • 23 Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8.
  • 24 Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-70.
  • 25 Allain CC, Chan CS, Richmond W, Fu PC, Poon LS. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20 (04) 470-5.
  • 26 Thomas AP, Delaville F. The use of fluorescent indicators for measurements of cytosolic free calcium concentration in cell populations and single cells. In: McCormark JG, Cobbold PH. eds. Cellular Calcium-A Practical Approach. New York: Oxford University Press; 1991: 1-53.
  • 27 Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-8.
  • 28 Larsin K. Creatinine assay by a reaction-kinetic approach. Clin Chem Acta 1972; 41: 209-17.
  • 29 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
  • 30 Fuhrman B, Brook GJ, Aviram M. Proteins derived from platelet a granules modulate the uptake of oxidized low density lipoprotein by macrophages. Biochem Biophys Acta 1992; 1127: 15-21.
  • 31 Witzum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785-92.
  • 32 Wang JS, Chow SE, Chen J-K, Wong MK. Effect of exercise training on oxidized LDL-mediated platelet function in rats. Thromb Heamost. 1999 accepted..
  • 33 Bauman WA, Spungen AM, Zhong YG, Rothstein JL, Petry C, Gordon SK. Depressed serum high density lipoprotein cholesterol levels in veterans with spinal cord injury. Paraplegia 1992; 30: 697-703.
  • 34 Brenes G, Dearwater S, Shaspera R, Laporte RE, Collins E. High density lipoprotein cholesterol concentrations in physically active and sedentary spinal cord injured patients. Arch Phys Med Rehabil 1986; 67: 445-50.
  • 35 Schreier L, Sanguinetti S, Mosso H, Lopez G, Siri L, Wikinski RLW. Low-density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease. Clin Biochem 1996; 29: 479-87.
  • 36 Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N Engl J Med 1995; 332: 1198-203.
  • 37 Minuz P, Andrioli G, Degan M, Gaino S, Ortolani R, Tommasoli R, Zuliani V, Lechi A, Lechi C. The F2-isoprostane 8-epiprostaglandin F increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Arterioscler Thromb Vasc Biol 1998; 189: 1248-56.
  • 38 Langille BL, O’Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 1988; 231: 405-7.
  • 39 Hopman MTE, Verheijen PHE, Binkhorst RA. Volume changes in the legs of paraplegic subjects during arm exercise. J Appl Physiol. 1993; 75 (05) 2079-83.